Business Description
Aethlon Medical Inc
NAICS : 339112
SIC : 5999
ISIN : US00808Y5050
Total Employee Number:
9Description
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 14.91 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -0.05 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 71.8 | |||||
3-Year EPS without NRI Growth Rate | 71.6 | |||||
3-Year FCF Growth Rate | 71.3 | |||||
3-Year Book Growth Rate | -81.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 59.67 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 19.01 | |||||
9-Day RSI | 19.72 | |||||
14-Day RSI | 23.6 | |||||
3-1 Month Momentum % | -19.57 | |||||
6-1 Month Momentum % | -31.52 | |||||
12-1 Month Momentum % | -86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.85 | |||||
Quick Ratio | 3.85 | |||||
Cash Ratio | 3.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -278.3 | |||||
Shareholder Yield % | -410.74 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -138.09 | |||||
ROA % | -104 | |||||
ROIC % | -482.72 | |||||
3-Year ROIIC % | -326.83 | |||||
ROC (Joel Greenblatt) % | -735.32 | |||||
ROCE % | -133.43 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 0.2 | |||||
Price-to-Tangible-Book | 0.2 | |||||
EV-to-EBIT | 0.43 | |||||
EV-to-EBITDA | 0.45 | |||||
EV-to-FCF | 0.44 | |||||
| Price-to-Net-Current-Asset-Value | 0.24 | |||||
| Price-to-Net-Cash | 0.27 | |||||
Earnings Yield (Greenblatt) % | 232.56 | |||||
FCF Yield % | -428.8 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AEMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aethlon Medical Inc Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -49.55 | ||
| Beta | 0.9522 | ||
| 3-Year Sharpe Ratio | 0.3 | ||
| 3-Year Sortino Ratio | 1.44 | ||
| Volatility % | 112.15 | ||
| 14-Day RSI | 23.6 | ||
| 14-Day ATR ($) | 0.118742 | ||
| 20-Day SMA ($) | 0.78347 | ||
| 12-1 Month Momentum % | -86 | ||
| 52-Week Range ($) | 0.59 - 27.4 | ||
| Shares Outstanding (Mil) | 2.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aethlon Medical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aethlon Medical Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2027-01-19 08:00 | In 182 days | ||
| Second quarter earnings conference call for 2027 | 2026-11-12 16:30 | In 114 days | ||
| Second quarter earnings results for 2027 | 2026-11-12 | In 113 days | ||
| First quarter earnings conference call for 2027 | 2026-08-13 16:30 | In 23 days | ||
| First quarter earnings results for 2027 | 2026-08-13 16:15 | In 23 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-06-10 16:30 | 1.94 (-3.48%) | ||
| Fourth quarter earnings results for 2026 | 2026-06-10 16:15 | 1.94 (-3.48%) | ||
| Annual report for 2026 | 2026-06-10 | 1.94 (-3.48%) | ||
| Emerging Growth Conference | 2026-02-25 12:30 | 2.01 (+0.75%) | ||
| Third quarter earnings conference call for 2026 | 2026-02-12 16:30 | 2.09 (-5.86%) |
Show
Entries
Aethlon Medical Inc Frequently Asked Questions
What is Aethlon Medical Inc(AEMD)'s stock price today?
The current price of AEMD is $0.62. The 52 week high of AEMD is $27.40 and 52 week low is $0.59.
When is next earnings date of Aethlon Medical Inc(AEMD)?
The next earnings date of Aethlon Medical Inc(AEMD) is 2026-08-13 Est..
Does Aethlon Medical Inc(AEMD) pay dividends? If so, how much?
Aethlon Medical Inc(AEMD) does not pay dividend.
Guru Commentaries on NAS:AEMD
No articles.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers